blister 发表于 2025-3-25 05:30:42

http://reply.papertrans.cn/43/4215/421482/421482_21.png

CANDY 发表于 2025-3-25 08:05:08

is suggested as a complement to X-ray mammography in order to overcome the drawbacks of handheld US. It was concluded that further research should be conducted to make the method clinically available in the future.

Priapism 发表于 2025-3-25 14:15:59

http://reply.papertrans.cn/43/4215/421482/421482_23.png

遗留之物 发表于 2025-3-25 19:20:09

http://reply.papertrans.cn/43/4215/421482/421482_24.png

顽固 发表于 2025-3-25 20:18:33

http://reply.papertrans.cn/43/4215/421482/421482_25.png

nurture 发表于 2025-3-26 01:37:48

http://reply.papertrans.cn/43/4215/421482/421482_26.png

杂色 发表于 2025-3-26 07:10:21

http://reply.papertrans.cn/43/4215/421482/421482_27.png

SPECT 发表于 2025-3-26 12:01:07

Incretin hormones as a target for therapy,Incretin hormones are responsible for the incretin effect, which is the amplification of insulin secretion when nutrients are taken in orally, as opposed to intravenously.

ARCHE 发表于 2025-3-26 16:04:03

Glucagon-like peptide-1 receptor agonists,Native glucagon-like peptide-1 (GLP-1) is not practical for therapeutic use due to a short half-life caused by ubiquitous, fast, and effective in vivo degradation by the enzyme dipeptidyl peptidase-4 (DPP-4).

绅士 发表于 2025-3-26 19:47:38

Dipeptidyl peptidase-4 inhibitors,Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
页: 1 2 [3] 4
查看完整版本: Titlebook: Handbook of Incretin-based Therapies in Type 2 Diabetes; Stephen Gough Book 2016 Springer International Publishing Switzerland 2016 Diabet